Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
Study sponsor: Eledon Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-09-11Actual
Enrollment · participants127Actual
Source updated2026-07-22Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.